trending Market Intelligence /marketintelligence/en/news-insights/trending/hkrm7konlvdnarewrigx5q2 content esgSubNav
In This List

Bal Pharma acquires drug ingredient manufacturer

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Bal Pharma acquires drug ingredient manufacturer

India's Bal Pharma Ltd. fully acquired M/s Golden Drugs Pvt. Ltd., which manufactures active pharmaceutical ingredients and bulk drugs.

The company acquired M/s Golden Drugs' shares at 20.66 Indian rupees each.

Bal Pharma provides pharmaceutical formulations and active pharmaceutical ingredients in India and internationally.

As of March. 22, US$1 was equivalent to 65.15 Indian rupees.